Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Sleep Consolidation
NCT04329091Phase 4Terminated
- Sponsor
- University of Chicago
- Start
- Oct 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine, sponsored by University of Chicago. Primary endpoint: Perceptual Learning Protocol at 1 day. Started Oct 2020; status: terminated.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT04329091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04329091.